![](/img/cover-not-exists.png)
Long term follow-up and outcomes of re-treatment in an expanded 50 patient single-center phase II prospective trial of Lutetium-177 ( 177 Lu) PSMA-617 theranostics in metastatic castrate-resistant prostate cancer
Violet, John, Sandhu, Shahneen, Iravani, Amir, Ferdinandus, Justin, Thang, Sue Ping, Kong, Grace, Ravi Kumar, Aravind, Akhurst, Tim, Pattison, David, Beaulieu, Alexis, Mooi, Jennifer, Guo, Christina,Journal:
Journal of Nuclear Medicine
DOI:
10.2967/jnumed.119.236414
Date:
November, 2019
File:
PDF, 2.46 MB
2019